Quantitative studies with antilymphocytic antibody.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMID 5299732)

Published in Nature on November 25, 1967

Authors

M F Woodruff, B L Reid, K James

Articles by these authors

The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26

The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18

BioJava: an open-source framework for bioinformatics. Bioinformatics (2008) 6.17

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst (2000) 5.62

Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts. Br J Cancer (1966) 4.85

Paraquat poisoning--lung transplantation. Br Med J (1968) 4.29

Renal transplantation in man. Experience in 35 cases. Lancet (1969) 3.67

Anti-lymphocytic antibody--a review. Clin Exp Immunol (1967) 2.75

Effect of antilymphocytic serum on the survival of renal homotransplants in dogs. Transplantation (1966) 2.38

BCG immunotherapy of bladder cancer: 20 years on. Lancet (1999) 2.38

Erythrocyte survival in normal mice and in mice with autoimmune haemolytic anaemia. Clin Exp Immunol (1966) 2.29

Human monoclonal antibody production. Current status and future prospects. J Immunol Methods (1987) 2.21

Laboratory staff qualifications and accuracy of proficiency test results. A national study. Arch Pathol Lab Med (1992) 2.07

The natural history of Peyronie's disease. J Urol (1990) 2.02

Clonal interaction in tumours. Nature (1982) 1.91

Effect of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro. Nature (1967) 1.89

Psychotic men remanded in custody to Brixton Prison. Br J Psychiatry (1994) 1.77

Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J (Clin Res Ed) (1983) 1.72

Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer (2003) 1.70

Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours. Br J Cancer (1972) 1.69

Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice. Clin Exp Immunol (1974) 1.69

Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol (1990) 1.66

Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol (1999) 1.63

A genomewide suppressor and enhancer analysis of cdc13-1 reveals varied cellular processes influencing telomere capping in Saccharomyces cerevisiae. Genetics (2008) 1.58

Puzzling changes in cervical cancer in young women. Med J Aust (1987) 1.56

Some factors influencing the ability of anti-lymphocytic antibody to suppress humoral antibody formation. Clin Exp Immunol (1967) 1.52

Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol (2002) 1.50

The preparation and properties of anti-lymphocytic sera. Prog Surg (1969) 1.48

Comparative effect of two strains of C. parvum on phagocytic activity and tumour growth. Nature (1968) 1.47

Anti-tumour effect in vitro of lymphocytes and macrophages from mice treated with Corynebacterium parvum. Br J Cancer (1974) 1.46

Possible implications of the effect of blood transfusion on allograft survival. Lancet (1983) 1.46

[Surgical treatment of the single non traumatic perforation of small bowel: excision-suture or resection-anastomosis]. Ann Chir (2005) 1.45

Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol (2000) 1.43

Structure-property correlations in a combinatorial library of degradable biomaterials. J Biomed Mater Res (1998) 1.42

Continuous thoracic epidural analgesia versus combined spinal/thoracic epidural analgesia on pain, pulmonary function and the metabolic response following colonic resection. Acta Anaesthesiol Scand (1996) 1.42

Effect of antilymphocytic antibody and antibody fragments on skin-homograft survival and the blood-lymphocyte count in rats. Lancet (1967) 1.41

Effect of anti-rat lymphocyte antibody on humoral antibody formation. Nature (1967) 1.40

Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol (1992) 1.38

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1996) 1.32

Purification of antilymphocytic antibody. Nature (1968) 1.30

Synergistic inhibition of mammary carcinoma transplants in A-strain mice by antitumour globulin and C. parvum. Br J Cancer (1971) 1.29

Characterization of antilymphocytic antibody. Nature (1967) 1.27

Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma. J Clin Oncol (1998) 1.27

Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg (1993) 1.26

The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1. Clin Exp Immunol (1983) 1.25

Multiple organ damage caused by a new toxin azaspiracid, isolated from mussels produced in Ireland. Toxicon (2000) 1.23

Cellular heterogeneity in tumours. Br J Cancer (1983) 1.23

Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice. J Natl Cancer Inst (1977) 1.21

New allele at cholinesterase locus 1. J Med Genet (1976) 1.20

Normal and pathological serum levels of alpha2-macroglobulins in men and mice. J Clin Pathol (1975) 1.18

Prolongation of canine renal allograft survival with antilymphocytic serum. Transplantation (1968) 1.16

A comparative study of anaerobic Coryneforms. Attempts to correlate their anti-tumour activity with their serological properties and ability to stimulate the lymphoreticular system. Immunology (1975) 1.16

The effect of passage in vitro and in vivo on the properties of murine fibrosarcomas I. Tumorigenicity and immunogenicity. Br J Cancer (1985) 1.15

The effect of anti-lymphocytic antibody on the humoral immune response in different strains of mice. I. The response to bovine serum albumin. Immunology (1972) 1.15

Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy. Clin Exp Immunol (1995) 1.14

Flexible eating and flexible insulin dosing in patients with diabetes: Results of an intensive self-management course. Diabetes Res Clin Pract (2008) 1.13

Inhibition of the growth of lymphoid tumours in syngeneic athymic (nude) mice. Int J Cancer (1977) 1.11

The antecedents of violence and aggression within psychiatric in-patient settings. Acta Psychiatr Scand (2012) 1.10

Studies on a unique diagnostic serum globulin in papular mucinosis (lichen myxedematosus). Clin Exp Immunol (1967) 1.10

Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma. Br J Cancer (1975) 1.09

Binding of C-reactive protein to human lymphocytes. II. Interaction with a subset of cells bearing the Fc receptor. J Immunol (1981) 1.08

Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study. J Urol (1993) 1.08

Preliminary observations on the effect of heterologous anti-lymphocytic globulin on autologous immune complex nephritis in rats. Clin Exp Immunol (1969) 1.06

Mechanisms of action of intravesical bacille Calmette-Guérin: local immune mechanisms. Clin Infect Dis (2000) 1.06

Binding of C-reactive protein to human lymphocytes. I. Requirement for a binding specificity. J Immunol (1981) 1.05

Distribution of fatty and fibrous plaques in young human coronary arteries. Atherosclerosis (1982) 1.05

Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids. Clin Exp Allergy (2008) 1.05

Role for CD40-CD40 ligand interactions in the immune response to solid tumours. Mol Immunol (2000) 1.05

A membrane-covered photobacterium probe for oxygen measurements in the nanomolar range. Anal Biochem (1981) 1.04

Prediction of amputation wound healing with skin perfusion pressure. J Vasc Surg (1995) 1.02

Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8. J Clin Oncol (2000) 1.02

Extracellular organelles (prostasomes) are immunosuppressive components of human semen. Clin Exp Immunol (1991) 1.02

Synovial cells. A study of the morphology and an examination of protein synthesis of synovial cells. Ann Rheum Dis (1966) 1.02

Sperm basic proteins in cervical carcinogenesis: Correlation with socioeconomic class. Lancet (1978) 1.01

Association of alpha-macroglobulins with lymphoid cells. Nat New Biol (1973) 1.01

The Nuffield transplantation surgery unit. Lancet (1968) 1.01

In vitro studies on the heterogeneity of equine antibodies to human lymphoid tissue. Immunochemistry (1969) 1.00

Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes. Immunology (1975) 1.00

Community empowerment in the control of lymphatic filariasis in Misima, Milne Bay Province using diethylcarbamazine in combination with albendazole. P N G Med J (2002) 0.99

The effect of anti-lymphocytic IgG on estab- lished autoallergic thyroiditis in rats. Clin Exp Immunol (1969) 0.99

Dppa3 is a marker of pluripotency and has a human homologue that is expressed in germ cell tumours. Cytogenet Genome Res (2003) 0.99

Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma. Br J Cancer (1976) 0.98

A hypothesis: the role of a high-risk male in the etiology of cervical carcinoma: a correlation of epidemiology and molecular biology. Am J Obstet Gynecol (1976) 0.98

Preliminary studies on the synthesis of alpha2-macroglobulin by human lymphocytes in vitro. Clin Exp Immunol (1974) 0.98

The effect of antilymphocytic antibody on the humoral immune response in different strains of mice. 3. The response to type 3 pneumococcus polysaccharide. Immunology (1973) 0.97

Association of host immunoglobulins with solid tumours in vivo. Br J Cancer (1979) 0.97

Lymphocyte sub-populations in the male genital tract. Br J Urol (1985) 0.97

Validation evidence for three coping measures. J Pers Assess (1995) 0.96

The production and characterisation of a panel of ten murine monoclonal antibodies to human procoagulant factor VIII. Thromb Haemost (1986) 0.96

A fluorescence polarization assay for inhibitors of Hsp90. Anal Biochem (2006) 0.96

Prolonged seated immobility at work is a common risk factor for venous thromboembolism leading to hospital admission. Intern Med J (2008) 0.95

Characteristics of peritoneal macrophages induced by asbestos injection. Environ Res (1982) 0.95

Effect of route of administration of antilymphocytic globulin on skin allograft survival in rats. Nature (1970) 0.95

Elimination of normal horse IgG labelled with Iodine-131 in rats receiving horse anti-rat lymphocytic IgG. Nature (1967) 0.95

The effect of antilymphocytic antibody on the primary immune response of mice to sheep erythrocytes, bovine serum albumin, and type 3 pneumococcus polysaccharide. Transplantation (1971) 0.94

UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. Biochem Biophys Res Commun (1989) 0.94